Early COVID-19 booster is beneficial in cancer patients.
10.47102/annals-acadmedsg.2022458
- Author:
Jens SAMOL
1
Author Information
1. Department of Medical Oncology, Tan Tock Seng Hospital, Singapore.
- Publication Type:Editorial
- MeSH:
Humans;
COVID-19;
Vaccination;
Neoplasms/epidemiology*
- From:Annals of the Academy of Medicine, Singapore
2023;52(1):3-5
- CountrySingapore
- Language:English